Results 21 to 30 of about 10,303 (292)

Equine allergic skin diseases: Clinical consensus guidelines of the World Association for Veterinary Dermatology

Veterinary Dermatology, Volume 34, Issue 3, Page 175-208, June 2023., 2023
Abstract Background Allergic skin diseases are common in horses worldwide. The most common causes are insect bites and environmental allergens. Objectives To review the current literature and provide consensus on pathogenesis, diagnosis, treatment and prevention. Materials and Methods The authors reviewed the literature up to November 2022.
R. Marsella, S. White, V. A. Fadok, D. Wilson, R. Mueller, C. Outerbridge, W. Rosenkrantz   +6 more
wiley   +1 more source

A randomised, double‐blinded comparison between subcutaneous rush and intralympathic allergen immunotherapy induction in atopic dogs

Veterinary Dermatology, Volume 34, Issue 2, Page 91-98, April 2023., 2023
Background – Atopic dermatitis (AD) is one of the most common skin diseases in small animal practice. Allergen immunotherapy (AIT) is the only curative treatment for the disease, and oral, subcutaneous and intralymphatic administration of allergens are commonly employed.
Ralf S. Mueller, Yuri Zablotski, Katja Baumann, Teresa Boehm, Bettina Kasper, Christoph Klinger, Maarten Monke, Laura Udraite‐Vovk, Tamara Weitzer, Natalie K. Y. Gedon   +9 more
wiley   +1 more source

Efficacy of subcutaneous allergen immunotherapy in atopic dogs: A retrospective study of 664 cases

Veterinary Dermatology, Volume 33, Issue 4, Page 321-e75, August 2022., 2022
Background –Canine atopic dermatitis (cAD) is an allergic skin disease affecting approximately 10% of dogs. Allergen immunotherapy (AIT) is currently the only treatment option able to induce tolerance to the causative allergens. Objective – To retrospectively establish the efficacy of AIT in atopic dogs.
Evelien E. M. Fennis, Catharina M. M. van Damme, Yvette M. Schlotter, Jacqueline D. Sinke, Mieke H. G. Leistra, Richard T. Bartels, Femke Broere   +6 more
wiley   +1 more source

Is there a role for HSF1 in viral infections?

FEBS Open Bio, Volume 12, Issue 6, Page 1112-1124, June 2022., 2022
Heat shock factor 1 (HSF1) plays important roles in the replication cycle of viruses. Numerous viruses have been found to modulate, or to be affected by the activation of HSF1. Depending on the virus, HSF1 can lead to detrimental effects over the virus (red line) or confer advantages to the virus (green arrows). Understanding the interplay between HSF1
Antonia Reyes, Areli J. Navarro, Benjamín Diethelm‐Varela, Alexis M. Kalergis, Pablo A. González   +4 more
wiley   +1 more source

The Role of Dendritic Cells During Infections Caused by Highly Prevalent Viruses

Frontiers in Immunology, 2020
Dendritic cells (DCs) are a type of innate immune cells with major relevance in the establishment of an adaptive response, as they are responsible for the activation of lymphocytes.
Jorge A. Soto, Nicolas M. S. Gálvez, Catalina A. Andrade, Gaspar A. Pacheco, Karen Bohmwald, Roslye V. Berrios, Susan M. Bueno, Alexis M. Kalergis, Alexis M. Kalergis   +8 more
doaj   +1 more source

Host–virus relationships: a sum of many battles

FEBS Open Bio, Volume 12, Issue 6, Page 1094-1095, June 2022., 2022
The spread of pathogenic viruses implies host infection, replication, and virus dissemination. In each step, viruses have to overcome the host defenses designed to neutralize the threat they pose. The host–virus relationship represents a constant multistage battle for power as the host/cell does not voluntarily give in to the viral enemy.
Marcelo López‐Lastra
wiley   +1 more source

Targeting the extra domain A of fibronectin for cancer therapy with CAR-T cells

Journal for ImmunoTherapy of Cancer, 2022
Background One of the main difficulties of adoptive cell therapies with chimeric antigen receptor (CAR)-T cells in solid tumors is the identification of specific target antigens.
Felipe Prosper, Sandra Hervás-Stubbs, Juan Jose Lasarte, Noelia Casares, Teresa Lozano, Diego Serrano, Carlos E De Andrea, Alfonso Calvo, Enrique Conde, Celia Martín-Otal, Aritz Lasarte-Cia, Flor Navarro, Inés Sánchez-Moreno, Marta Gorraiz, Patricia Sarrión, José Echeveste, Amaia Vilas, Juan Roberto Rodriguez-Madoz, Jesús San Miguel   +18 more
doaj   +1 more source

Inmunoterapia en melanoma [PDF]

Oncología (Barcelona), 2004
La cirugía temprana es el único método con efectividad clínica demostrada en el tratamiento del melanoma maligno. La capacidad del melanoma para generar una respuesta inmunitaria efectora, junto a su frecuente resistencia a la quimioterapia y radioterapia, conduce a la búsqueda de soluciones terapéuticas en la manipulación del sistema inmunitario.
Torrella, A., Noris-García, E.
openaire   +3 more sources

Complicaciones neurológicas relacionadas con la inmunoterapia en pacientes oncológicos

Revista Médica Clínica Las Condes
Gabriela Montecinos, Florencia del Río
openalex   +2 more sources

Immunopathogenesis and immunotherapy of Culicoides hypersensitivity in horses: an update

Veterinary Dermatology, Volume 32, Issue 6, Page 579-e156, December 2021., 2021
Culicoides hypersensitivity (CH) is a strongly pruritic dermatitis of horses, characterised histologically by mixed perivascular to diffuse cellular infiltrates of mononuclear cells and eosinophils, and caused by helper T cell (Th)2, immunoglobulin (Ig)E‐mediated reactions to antigens present in the saliva of biting Culicoides midges.
Eliane Marti, Ella N. Novotny, Iva Cvitas, Anja Ziegler, A. Douglas Wilson, Sigurbjörg Torsteinsdottir, Antonia Fettelschoss‐Gabriel, Sigridur Jonsdottir   +7 more
wiley   +1 more source